Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?
- PMID: 31277749
- DOI: 10.1016/j.rdc.2019.04.008
Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?
Abstract
Hydroxychloroquine and quinacrine are frequently used to treat rheumatic diseases. Ocular toxicity, although infrequent, is one of the potential side effects of antimalarial therapies. Current recommendations are unifocal in being developed by only ophthalmologists who do not treat patients for their rheumatic diseases. The data used to create the recommendations are meager and retrospective. Comanagement of patients with rheumatic disease who are exposed to antimalarial therapies requires a greater interaction between ophthalmologists and rheumatologists.
Keywords: Antimalarials; Hydroxychloroquine; Ocular toxicity; Quinacrine; Retinopathy.
Copyright © 2019 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
